The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas
- 1 July 2000
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 11-22
- https://doi.org/10.1016/s0169-5002(00)00118-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Is Angiopoietin-2 Necessary for the Initiation of Tumor Angiogenesis?The American Journal of Pathology, 1998
- Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colonHuman Pathology, 1998
- Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal NeovascularizationCirculation Research, 1998
- Angiopoietin-1 induces sprouting angiogenesis in vitroCurrent Biology, 1998
- Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo AngiogenesisScience, 1997
- Signaling Vascular Morphogenesis and MaintenanceScience, 1997
- Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxiaOncogene, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Blood Vessel Formation: What Is Its Molecular Basis?Cell, 1996
- Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression CloningCell, 1996